confusing the news about Avandia and Actos

Some people are confusing the news about Avandia and Actos.

Avandia products will all but disappear...due to cardiac concerns.

After November 18th, prescribers and patients will have to be enrolled in the Avandia-Rosiglitazone Medicines Access Program to prescribe or get rosiglitazone.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote